产品名称
蛋白酶抑制剂混合物套装 IV - CA&, The Protease Inhibitor Cocktail Set IV controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
form
liquid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
solubility
water: soluble
shipped in
wet ice
storage temp.
−20°C
Application
蛋白酶抑制剂混合物 IV,是四种蛋白酶抑制剂的混合物,对天冬氨酸、半胱氨酸 & 金属丝氨酸蛋白酶具有广泛的特异性。推荐用于真菌 & 酵母细胞。
Biochem/physiol Actions
主靶
天冬氨酸、半胱氨酸、金属和丝氨酸蛋白酶
天冬氨酸、半胱氨酸、金属和丝氨酸蛋白酶
产品不与 ATP 竞争。
广泛抑制丝氨酸蛋白酶、半胱氨酸蛋白酶、天冬氨酸蛋白酶和金属蛋白酶。
Disclaimer
毒性:有毒(F)
General description
四种蛋白酶抑制剂混合物,对天冬氨酸、半胱氨酸、金属和丝氨酸蛋白酶具有广泛的特异性。推荐用于真菌和酵母细胞提取物。每个小瓶均包含 100 mM AEBSF,HCl(货号 101500),1.5 mM E-64(货号 324890),2mM 抑肽酶 A(货号 516481),和 500 mM 1,10-菲咯啉(货号 516705)。随附数据表。注意:1 个套装= 5 x 1 ml。
蛋白酶抑制剂混合物 IV 控制蛋白酶的活性。这种小分子/抑制剂主要用于蛋白酶抑制剂的应用。
Other Notes
由于该运输中有害物质的性质,您的订单可能需要支付额外的运输费用。某些尺寸的产品可免除其他有害材料的运输费用。请与您当地的销售办事处联系,以获取有关这些费用的更多信息。
Physical form
溶于 1 ml DMSO.
Preparation Note
蛋白酶抑制剂混合物套装 IV 可以以 1:100-1:1000 的稀释度用于大多数应用。
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Irrit. 2
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
188.6 °F - Information refers to the main ingredient.
flash_point_c
87 °C - Information refers to the main ingredient.
法规信息
新产品
此项目有
Joseph V Geisberg et al.
Current protocols in molecular biology, 128(1), e101-e101 (2019-09-11)
Here we describe CLIP-READS, a technique that combines elements of crosslinking and immunoprecipitation (CLIP) and 3' region extraction and deep sequencing (READS), to provide a genome-wide map of mRNA 3' isoform binding by a given messenger ribonucleoprotein (mRNP). In CLIP-READS
Haneul Yoo et al.
STAR protocols, 3(2), 101409-101409 (2022-05-24)
Heat stress triggers a specific set of proteins in budding yeast to form solid-like biomolecular condensates, which are dispersed by molecular chaperones. Here, we describe a protocol to study the kinetics of chaperone-facilitated condensate dispersal using biochemical reconstitution and fluorescence anisotropy.
Zhouying Wu et al.
Frontiers in molecular biosciences, 8, 707295-707295 (2021-09-14)
The inhibitor of CDK4/6 has been clinically used for treating certain types of cancer which are characterized by G0/G1 acceleration induced by the CDK4/6-RB1 pathway. On the contrary, the cell cycle-related molecules are abnormal in over 50% of the patients
Micaela Boiero Sanders et al.
The EMBO journal, 41(5), e107982-e107982 (2022-02-19)
A paradox of eukaryotic cells is that while some species assemble a complex actin cytoskeleton from a single ortholog, other species utilize a greater diversity of actin isoforms. The physiological consequences of using different actin isoforms, and the molecular mechanisms
Brian K Haarer et al.
Bio-protocol, 13(23), e4894-e4894 (2023-12-14)
Eukaryotic cells rely on actin to support cellular structure, motility, transport, and a wide variety of other cytoplasmic functions and nuclear activities. Humans and other mammals express six closely related isoforms of actin, four of which are found primarily in
相关内容
An Introduction to Inhibitors and Their Biological Applications
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
